Researchers used CRISPR to remove the CD33 protein from donor stem cells, protecting healthy blood cells from therapies that ...

Gene-editing is like enhanced classical breeding but done at the molecular level and does not introduce any foreign genes and ...

The next six months may be decisive for the biotech.

From seedless blackberries to cancer therapies, CRISPR is transforming food production, healthcare and agriculture.

Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, targeting atherosclerotic cardiovascular disease. Read the more here.

Add Yahoo as a preferred source to see more of our stories on Google. Stanford researchers have developed CRISPR-GPT, an AI-powered copilot that guides gene-editing experiments. (CREDIT: Shutterstock) ...

CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping the future of medicine and genetics.

Zilong Qiu is now being investigated by his university more than a year after his patient likely died from his team's ...

CASGEVY is a non-viral, ex vivo, CRISPR/Cas9 gene-edited cell therapy for eligible patients with SCD or TDT that has been ...